David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Cal-Maine
CALM
$3.88B
| $1.92M | ﹤0.01% |
19,258
+16,856
| +702% | +$1.61M |
|
|
SPKL
2652
Spark I Acquisition Corp
SPKL
$100M
| $1.91M | ﹤0.01% |
175,145
| – | – |
|
2653
CALL
Thermo Fisher Scientific
TMO
$234B
| $1.91M | ﹤0.01% |
4,700
+3,600
| +327% | +$1.51M |
|
|
VBTX
2654
DELISTED
Veritex Holdings
VBTX
| $1.9M | ﹤0.01% |
72,926
+44,281
| +155% | +$1.06M |
|
2655
CALL
First Majestic Silver
AG
$10.3B
| $1.9M | ﹤0.01% |
230,000
-43,000
| -16% | -$289K |
|
2656
Cathay General Bancorp
CATY
$4.14B
| $1.9M | ﹤0.01% |
41,746
+34,297
| +460% | +$1.46M |
|
2657
Eaton
ETN
$163B
| $1.89M | ﹤0.01% |
5,301
-135,086
| -96% | -$41.6M |
|
|
GTY
2658
Getty Realty Corp
GTY
$2.06B
| $1.88M | ﹤0.01% |
68,198
-8,042
| -11% | -$231K |
|
|
GOOS
2659
CALL
Canada Goose Holdings
GOOS
$793M
| $1.88M | ﹤0.01% |
+168,400
| New | +$1.63M |
|
2660
Tencent Music
TME
$14.4B
| $1.88M | ﹤0.01% |
96,472
+41,568
| +76% | +$653K |
|
2661
Valero Energy
VLO
$100B
| $1.88M | ﹤0.01% |
+13,980
| New | +$1.74M |
|
2662
Covenant Logistics
CVLG
$902M
| $1.88M | ﹤0.01% |
77,871
-12,424
| -14% | -$269K |
|
2663
AMERISAFE
AMSF
$487M
| $1.88M | ﹤0.01% |
42,894
+32,729
| +322% | +$1.54M |
|
|
CFLT
2664
PUT
DELISTED
Confluent
CFLT
| $1.87M | ﹤0.01% |
+75,100
| New | +$1.69M |
|
2665
ATS Corp
ATS
$1.95B
| $1.87M | ﹤0.01% |
58,572
+27,672
| +90% | +$758K |
|
2666
Aldeyra Therapeutics
ALDX
$94.1M
| $1.87M | ﹤0.01% |
487,672
+336,030
| +222% | +$869K |
|
2667
Mondelez International
MDLZ
$80.4B
| $1.87M | ﹤0.01% |
+27,676
| New | +$1.85M |
|
2668
National Bank Holdings
NBHC
$1.84B
| $1.86M | ﹤0.01% |
49,567
+29,187
| +143% | +$1.06M |
|
|
VRNA
2669
CALL
DELISTED
Verona Pharma
VRNA
| $1.86M | ﹤0.01% |
+19,700
| New | +$1.46M |
|
2670
CALL
Innodata
INOD
$1.92B
| $1.86M | ﹤0.01% |
36,300
+16,000
| +79% | +$631K |
|
|
CIO
2671
DELISTED
City Office REIT
CIO
| $1.85M | ﹤0.01% |
347,007
-35,860
| -9% | -$180K |
|
2672
AngloGold Ashanti
AU
$59.7B
| $1.85M | ﹤0.01% |
40,588
-92,549
| -70% | -$3.98M |
|
2673
Inspire Medical Systems
INSP
$1.79B
| $1.85M | ﹤0.01% |
14,222
-373
| -3% | -$54.1K |
|
2674
Ecopetrol
EC
$34B
| $1.84M | ﹤0.01% |
+208,080
| New | +$1.84M |
|
2675
PUT
Kadant
KAI
$3.61B
| $1.84M | ﹤0.01% |
+5,800
| New | +$1.82M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.